Acceptance and use of MDSAP certificates is growing worldwide, with the pathway of reliance making it easier for manufacturers to comply with the QMS regulatory requirements of multiple regulatory authorities.
This document sets out the roles and responsibilities of the MDSAP Industry Group and provides clarification on the group’s purpose, roles, responsibilities, operations, tenure and obligations in accordance with agreed terms with the MDSAP Regulatory Authority Council.
The 2026 MDSAP Forum, hosted by Japan’s Ministry of Health, Labour and Welfare, and the Japanese Pharmaceuticals and Medical Devices Agency, will be held in Kyoto from Monday 15 June 2026 to Friday 19 June 2026.
The MDSAP Regulatory Authority Council is pleased to announce it has reviewed and accepted two new AO applications from Kiwa Ltd and mdc medical device certification GmbH.